Evomela Prices, Coupons, Copay Cards & Patient Assistance
Evomela (melphalan) is a member of the alkylating agents drug class and is commonly used for Multiple Myeloma.
The cost for Evomela 50 mg intravenous powder for injection is around $1,717 for a supply of 1 powder for injection, depending on the pharmacy you visit. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
A generic version of Evomela is available. See melphalan prices (from $178.00 for 1 powder for injection).
Evomela prices
Intravenous Powder For Injection
50 mg
Evomela intravenous powder for injection
from $1,716.96
for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $1,716.96 | $1,716.96 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Drugs.com Printable Discount Card
The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.
Print Free Discount CardNote: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, Target, WalMart Pharmacy, Duane Reade and 65,000 pharmacies nationwide.
Evomela Coupons, Copay Cards and Rebates
Evomela offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Evomela STAR Copay Assistance Program
Eligible commercially insured patients will pay $0 copay for the 1st date of service and then pay $25 for each subsequent date of service.
- Applies to:
- Evomela
- Number of uses:
- per prescription per calendar year
Form more information phone: 888-537-8277 or Visit website
Patient Assistance & Copay Programs for Evomela
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Evomela (melphalan) Injection; IV
More information please phone: 866-316-7263 Visit Website
Provider: Specialty Therapy Access Resources (STAR)
Eligibility requirements:- Contact program for details.
- Not disclosed
- Not specified
- US residency requirements are not specified.
- Co-payment assistance, reimbursement support, patient support, and patient assistance programs are available for eligible patients.
- Evomela (melphalan) Injection; IV
More information please phone: 888-537-8277 Visit Website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Abecma
Abecma is a CAR T cell therapy used to treat relapsed refractory multiple myeloma (RRMM); it is a ...
Tecvayli
Tecvayli (teclistamab) is a treatment for relapsed or refractory multiple myeloma. Includes ...
Carvykti
Carvykti (ciltacabtagene autoleucel) is a treatment for relapsed or refractory multiple myeloma ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Decadron
Decadron is used for addison's disease, adrenal insufficiency, adrenocortical insufficiency ...
Revlimid
Revlimid is used to treat types of multiple myeloma, mantle cell lymphoma, follicular lymphoma and ...
Darzalex
Darzalex (daratumumab) is a target therapy used to treat multiple myeloma. Includes DARZALEX uses ...
Velcade
Velcade injection is used to treat multiple myeloma and mantle cell lymphoma. Includes Velcade side ...
Pomalyst
Pomalyst (pomalidomide) is used to treat multiple myeloma and AIDS-related Kaposi sarcoma. Includes ...
More about Evomela (melphalan)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: alkylating agents
- En español
